If you've been waiting for a different type of COVID vaccine, 'now is the time to join the millions of Americans who have been vaccinated,' says CDCDirector.
citizens with another option."From a scientific standpoint, I think the fact that we have another tool to be able to mix and match with other vaccines to come up with theand an initial vaccine series is going to be important," Dr. Adalja adds.
"Having multiple types of vaccines offers more options and flexibility for the public, jurisdictions, and vaccine providers," the CDC said in"The chief difference that this is a protein-based vaccine, as Moderna and Pfizer vaccines are mRNA-based and the Johnson & Johnson uses a different virus to deliver the spike protein of SARS-CoV-2," Dr. Adalja says.
That being said, because the Novavax vaccine uses a spike protein based on the"ancestral" strain of the virus ,"it will likely have difficulty in preventinginfections from Omicron variants, just like the current other current vaccines," Dr. Adalja says. But one thing that differs in Novavax is that the spike protein is coupled with an adjuvant,"a substance that stimulates the immune system," Dr.
Common side effects are similar to other vaccines, including fatigue, tenderness or pain at the injection site, headache, and muscle pain. The FDA also recently published data showing the vaccine may cause myocarditis and pericarditis, albeit rarely, news that caused the company's stock price to dip, reports
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CDC advisory panel votes to recommend the Novavax Covid vaccineA green light from the CDC will pave the way for 3.2 million doses of the Novavax vaccine to be distributed in the United States.
Read more »
NPR Cookie Consent and Choices
Read more »
Statement from HHS Secretary Xavier Becerra on the Authorization of Protein-Based Novavax COVID-19 VaccineToday, SecBecerra released a statement supporting CDCgov recommendation to make the protein-based Novavax COVID19 vaccine available to all Americans aged 18 and up. Read more here:
Read more »
CDC endorses more traditional Novavax COVID shot for adultsHealth officials say U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax.
Read more »
Novavax's COVID vaccine gets CDC panelIt is the fourth COVID shot authorized for use in the U.S.
Read more »
CDC advisers endorse more traditional Novavax COVID shotGovernment advisers say U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax.
Read more »